Related Experiment Video
Updated: Jan 20, 2026

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
Published on: April 28, 2023
Synergy between arsenic trioxide and JQ1 on autophagy in pancreatic cancer
Congling Xu1,2, Xinrui Wang1, Yu Zhou3
1State Key Laboratory for Medical Genomics, Shanghai Institute of Hematology, Rui-Jin Hospital Affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Abstract:
Pancreatic cancer is a deadliest type of malignancy and lacks effective intervention. We here report a potential strategy for treatment of this malignancy by the combination of arsenic trioxide (ATO) and BET bromodomain inhibitor JQ1. These two agents synergistically modulate multistages of autophagy and thus induce apoptosis effectively in pancreatic cancer cells. Our genomic and biochemical data have demonstrated that crosstalks between ER stress and autophagy play crucial roles during ATO-induced apoptosis, in which NRF2 may stand at the crossroad between cell death and survival. This has been further strengthened by our finding that NRF2 depletion renders insensitive cells into sensitive ones in regard to ATO treatment-caused cell death. The knockdown of NRF2 and the addition of JQ1 result in similar molecular/cellular effects in promoting effective ATO-induced apoptosis in cells that are insensitive to ATO treatment alone. Thus, the combination of ATO and JQ1 may represent a new treatment strategy for pancreatic cancer.
Insights
This study reveals a novel pancreatic cancer treatment combining arsenic trioxide (ATO) and BET inhibitor JQ1. This combination synergistically induces apoptosis by modulating autophagy and ER stress, offering a promising strategy for this deadly malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Pancreatic cancer is a highly lethal malignancy with limited effective treatment options.
- Understanding the molecular mechanisms of cell death is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the synergistic effect of arsenic trioxide (ATO) and JQ1 in treating pancreatic cancer.
- To elucidate the role of autophagy, ER stress, and NRF2 in ATO-induced apoptosis.
Main Methods:
- Combination treatment of pancreatic cancer cells with ATO and JQ1.
- Genomic and biochemical analyses to study autophagy, ER stress, and NRF2.
- NRF2 depletion experiments to assess its role in treatment sensitivity.
Main Results:
- ATO and JQ1 synergistically induce apoptosis in pancreatic cancer cells.
- The combination modulates autophagy and ER stress, crucial pathways in ATO-induced cell death.
- NRF2 plays a key role in cell survival, and its depletion enhances sensitivity to ATO.
Conclusions:
- The combination of ATO and JQ1 represents a potential new therapeutic strategy for pancreatic cancer.
- Targeting the interplay between ER stress, autophagy, and NRF2 could overcome treatment resistance.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Cancer

